Latest Competition News

Polymetals Resources Ltd has successfully completed a $15 million equity raise to replace debt and support the production ramp-up at its Endeavor Mine in New South Wales.

VBX Limited has successfully listed on the ASX and revealed strong preliminary feasibility results for its Wuudagu Bauxite Project, positioning itself to capitalize on rising bauxite demand and supply uncertainties.

Archer Materials advances its quantum computing and medical diagnostics technologies, extending key partnerships and forming a new advisory board while maintaining a strong cash position to fuel development.

Iris Cairns Property Pty Ltd has agreed to acquire Reef Casino Trust in a $177 million cash takeover bid, endorsed unanimously by the Reef Casino Trust board and its largest unitholders.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Energy Transition Minerals has submitted a binding offer to acquire the Penouta Mine in Spain, a critical asset for Europe’s supply of tantalum and niobium. The outcome hinges on regulatory approvals and competitive bidding.

Macquarie Technology Group’s subsidiary has secured an option to acquire a prime Sydney site for a major new data centre campus, aiming to boost capacity for AI, cloud, and government clients.

Indiana Resources appoints seasoned mining executive Matthew Bowles as Managing Director to spearhead expansion at its Minos Gold Project, while promoting John Fitzgerald to COO amid a strong cash position.

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.

Australian Strategic Materials unveils a transformative heap leach approach for its Dubbo Project, cutting upfront capital costs by over half and accelerating rare earth oxide production amid rising global demand.